Drug Resistance

Un caso di pericardite recidivante colchicina-resistente

Maggio MC, Alizzi C, Di Leto E, Ippolito A, Sferlazza F, Corsello G

2023/6 — pag. 111-112 — DOI

A 9-year-old boy affected by colchicine-resistant idiopathic pericarditis was successfully treated with an IL-1 receptor antagonist (anakinra)....

Pioglitazone e C3-glomerulopathy... che emozione!

Balestra E, Canepari E, Pennesi M

2022/7 — pag. 148-149 — DOI

The Authors describe the case of a 17-year-old girl with drug resistant C3-glomerulopathy who responded well to the therapy with pioglitazone. The efficacy and safety of the drug in the refractory nephrotic syndromes is discussed....

La polmonite acquisita in comunità

Iacono A, Troisi A, Marchetti F

2021/8 — pag. 515-518 — DOI

Community-acquired pneumonia (CAP) is one of the most common serious infections in children. The appropriate duration of antimicrobial therapy is unclear. In current practice antibiotic treatment courses of 10 days are prescribed in mild-moderate CAP...

Un asma sine asma: la SIRT

Contorno S

2021/2 — pag. 57-57 — DOI

The paper describes the case of a girl with recurrent cough attributable to the so-called Cough Hypersensitivity Syndrome (CHS). The cough was misdiagnosed as drug resistant asthma for long time. CHS should be considered in all cases where recurrent,...

Malattia di Kawasaki: quale dose di immunoglobuline nei bambini grandi?

L. Mambelli, A. Iacono, G. Rametta, F. Marchetti

2020/9 — pag. 231-233 — DOI

In a retrospective study conducted on a population of Japanese children with a weight ≥ 25 kg and with Kawasaki disease, no significant difference has been observed for the onset of coronary aneurysms, intravenous immunoglobulin (IVIg) resistan...

La sindrome nefrosica in età pediatrica

Consensus della Società Italiana di Nefrologia Pediatrica (SINePe)

2019/9 — pag. 577-588

In Italy are not guidelines for the management of idiopathic nephrotic syndrome (NS) in paediatric age. The choice of a treatment with steroids has always been based on the clinical experience of each centre. The present Consensus of the Italian Paed...

Un neonato a termine ipotonico: pensa anche alla sindrome di Prader-Willi

M.C. Bariola, E. Vaccina, L. Lugli, A. Berardi, L. Lucaccioni, L. Iughetti, F. Ferrari

2019/1 — pag. 52-54

The paper describes the case of a term newborn infant, born by elective caesarean section with no prenatal and perinatal risk factors. He presented with an unexpected cardiorespiratory depression at birth, severe hypotonia, feeding problems and pecul...

Quando la rettocolite ulcerosa diventa una sfida per il medico

G.M. Sciarrabone, M. Citrano, R. Ganci, M. Violante, N. Cassata

2017/8

Linfoma di Hodgkin in sindrome nefrosica

M. Pennesi

2017/6

Storie di pediculosi... angoscianti

F. Fusco

2017/5 — pag. 321-322

Una Kawasaki troppo resistente!

N.S. Carucci

2016/9

Il trattamento della sindrome nefrosica cortico-sensibile

V. Murgia, F. Pugliese, F. Emma, G. Montini, M. Pennesi

2016/5 — pag. 297-302

Nephrotic cortico-sensitive syndrome is a chronic disease difficult to manage. Indeed, it presents a relapse risk in about 90% of cases and it may develop steroid dependence/ frequent relapse in about 50% of children. The nephrologist and the paedi...

Score predittivo di malattia di Kawasaki refrattaria: dati della Clinica Pediatrica di Palermo

M.C. Maggio, E. Prinzi, G. Corsello

2014/10

Staminali

2011/1 — pag. 51-52

Linfoadenite laterocervicale tubercolare: terapia medica, chirurgica ed effetti paradossi

G. Tornese, A. Tedeschi, D. Codrich, C. Fabris, F. Marchetti

2008/1

Anemia emolitica autoimmune in un bambino di 7 anni con colite ulcerosa

C. Brondello, M. Lorusso, E. Pozzi, F. Bronzini, F. Mangiantini, M. de Martino, P. Lionetti

2007/9

Il pediatra e la resisitenza agli steroidi

N. Giurici, S. Crocco, E. Barbi

2007/8 — pag. 533

Despite the availability of new immunomodulators, steroids still represent a milestone of Inflammatory Bowed Disease (IBD) therapy. Steroid resistance in IBD is an uncommon, yet existing and epidemiologically defined event involving one fifth of th...

Il pediatra e la resistenza agli steroidi nella colite ulcerosaDalla clinica alle basi molecolari: riconoscerla e trattarla

N. Giurici, S. Crocco, E. Barbi

2007/8

Ritorno dell'efficacia della clorochina nella prevenzione e nella cura della malaria nel Malawi

G. Bartolozzi

2007/5

Un trattamento efficace, non farmacologico, contro i pidocchi: l'aria calda

G. Bartolozzi

2006/9

Resistenza e ipersensibilità ai corticosteroidi. Dalla clinica alle basi molecolari: andata e ritorno

I. Drigo, A. Saccari, C. Bacchin, F. Bartoli, E. Barbi, F. Ceschin, A. Ventura, G. Decorti

2006/4 — pag. 241-247

Steroids are among the drugs of most common use in paediatric practice. This widespread use does not usually correspond to a thorough knowledge of the mechanisms underlying steroid pharmacology, especially of the steroid resistance and hypersensitivi...

La tubercolosi in Europa e negli USA

G. Bartolozzi

2004/4

La tubercolosi (seconda parte)

G. Bartolozzi

2004/2

Piastrinopenia cronica multiresistente in bambina con sindrome linfoproliferativa autoimmune (ALPS). Efficacia della ciclofosfamide

E. Barth, M. Rabusin G.A. Zanazzo, P. Tamaro

2001/8

Piastrinopenia cronica multiresistente in bambina con sindrome linfoproliferativa autoimmune (ALPS): efficacia della ciclofosfamide

E. Barth, M. Rabusin, GA. Zanazzo, P. Tamaro

2001/8 — pag. 548-548

Report of a very severe case of thrombocytopenia with lymphoproliferative autoimmune syndrome (hereditary ALPS) resistant to classical treatments, both in high doses or bolus, with prompt and durable response to cyclophosfamide....

Sindrome di Gilles de la Tourette: descrizione di un caso trattato con pimozide

D. Mangione

2001/7 — pag. 464

An 8-year old boy had three relapses of Gilles de la Tourette syndrome. The last one, previously treated with haloperidole and resistant to treatment with flufenazine, was responsive promptly to pimozide 6 mg per day....

Un asma che non risponde al cortisone

M.T. Calipa, M. Pocecco

1997/7 — pag. 455-459